Moreover, NFκB activation, a hallmark of the MES phenotype in gliomas, promotes the expression of a series of matrix regulators such as Serpine1, Plau (plasminogen activator, urokinase) and TIMP1, inducing tumor proliferation and growth [105]. Here, NFKB1 is linked to glioma.